Regulatory
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Search
Who we are
NCF International
Regulatory
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Home
Pharmacovigilance
Pharmacovigilance
Big data for pharmacovigilance studies
Caterina Lucchini
7 March 2019
Polypharmacy
Drug interactions deserve deeper attention
Treatment guidelines currently in use are generally based on mono-therapies. The debate is open as for the need to consider also drug interactions, a frequent occurrence in polytherapy regimes
Giuliana Miglierini
6 October 2015
Adverse drug reactions: the EU-ADR Alliance project
Cristiana Bernini
8 April 2013